Indeed, we confirmed its efficacy at 20 μM concentration in accord with previous data reporting that in cell cultures it acts at concentrations as low as 5-20 μM, and in mice it reduces p53-defective cancer cells growth at the daily dose of 2.5 mg/kg [32]. Here, TP53 is linked to cancer.